Jason S Hauptman
Overview
Explore the profile of Jason S Hauptman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
752
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gust J, Cole B, Ronsley R, Wilson A, Seidel K, Wendler J, et al.
Neuro Oncol
. 2025 Mar;
PMID: 40070357
Background: Relapsed/refractory pediatric CNS tumors have a poor prognosis. EGFR is commonly overexpressed, but EGFRvIII mutations are uncommon. To target these tumors, we used chimeric antigen receptor (CAR) T cells...
2.
Yengo-Kahn A, Wellons J, Jensen H, Kulkarni A, Chu J, Hauptman J, et al.
J Neurosurg Pediatr
. 2025 Feb;
:1-11.
PMID: 39919296
Objective: Conditional survival incorporates the effect of time passed since an event to current data in an easy-to-understand, relevant format. Data from the Hydrocephalus Clinical Research Network (HCRN) registry were...
3.
Isaacs A, Shannon C, Browd S, Hauptman J, Holubkov R, Jensen H, et al.
J Neurosurg Pediatr
. 2025 Jan;
:1-12.
PMID: 39889292
Objective: This study investigated neurodevelopmental outcomes in preterm neonates with posthemorrhagic hydrocephalus (PHH), focusing on the comparative effectiveness of temporary and permanent CSF diversion strategies. Methods: This multicenter prospective observational...
4.
Hauptman J, Antonios J, Mathern G, Levine M, Cepeda C
Cells
. 2025 Jan;
14(2).
PMID: 39851507
Abnormalities in the mammalian target of the rapamycin (mTOR) pathway have been implicated in numerous developmental brain disorders. While the molecular and histological abnormalities have been described, less is known...
5.
Vitanza N, Ronsley R, Choe M, Seidel K, Huang W, Rawlings-Rhea S, et al.
Nat Med
. 2025 Jan;
PMID: 39775044
Diffuse intrinsic pontine glioma (DIPG) is a fatal central nervous system (CNS) tumor that confers a median survival of 11 months. As B7-H3 is expressed on pediatric CNS tumors, we...
6.
Goldstein H, Poliakov A, Barry D, Warner M, Shaw D, Novotny E, et al.
J Neurosurg Pediatr
. 2024 Dec;
35(3):266-275.
PMID: 39729583
Objective: Functional MRI (fMRI) helps with the identification of eloquent cortex to assist with function preservation in patients who undergo epilepsy surgery. Language and memory tasks can even be used...
7.
Malhotra A, Kulkarni A, Verhey L, Reeder R, Riva-Cambrin J, Jensen H, et al.
Childs Nerv Syst
. 2024 Dec;
41(1):42.
PMID: 39658658
Purpose: This Hydrocephalus Clinical Research Network (HCRN) study had two aims: (1) to compare the predictive performance of the original ETV Success Score (ETVSS) using logistic regression modeling with other...
8.
Simon T, Rezvan P, Coffin S, Hall M, Hauptman J, Kronman M, et al.
J Neurosurg Pediatr
. 2024 Jul;
34(4):357-364.
PMID: 39029119
Objective: The Hydrocephalus Clinical Research Network (HCRN) implemented a perioperative infection prevention bundle for all CSF shunt surgeries in 2007 that included the relatively unproven technique of intrathecal instillation of...
9.
Ravindra V, Riva-Cambrin J, Jensen H, Whitehead W, Kulkarni A, Limbrick D, et al.
J Neurosurg Pediatr
. 2024 Jul;
34(4):305-314.
PMID: 38968629
Objective: When the peritoneal cavity cannot serve as the distal shunt terminus, nonperitoneal shunts, typically terminating in the atrium or pleural space, are used. The comparative effectiveness of these two...
10.
Podkovik S, Zhou C, Coffin S, Hall M, Hauptman J, Kronman M, et al.
BMC Pediatr
. 2024 May;
24(1):325.
PMID: 38734598
Background: Cerebrospinal fluid (CSF) shunts allow children with hydrocephalus to survive and avoid brain injury (J Neurosurg 107:345-57, 2007; Childs Nerv Syst 12:192-9, 1996). The Hydrocephalus Clinical Research Network implemented...